A vitamin D, metabolite in intestine more polar than 25-hydroxy-vitamin Vitamin D is believed to function in the regulation of calcium absorption from the gut by controlling the expression of genetic information (1, 2). Several groups hypothesize that vitamin D induces the synthesis of mRNA and a special protein(s) that comprises part or all of a calcium transport system in the intestinal mucosa cell. A calcium-binding protein induced by vitamin D has been isolated from the chick gut (3), and the vitamin has been shown to increase strikingly the Ca++-ATPase (4) and alkaline phosphatase (5) activity of intestinal microvillar membranes.
Vitamin D is believed to function in the regulation of calcium absorption from the gut by controlling the expression of genetic information (1, 2) . Several groups hypothesize that vitamin D induces the synthesis of mRNA and a special protein(s) that comprises part or all of a calcium transport system in the intestinal mucosa cell. A calcium-binding protein induced by vitamin D has been isolated from the chick gut (3) , and the vitamin has been shown to increase strikingly the Ca++-ATPase (4) and alkaline phosphatase (5) activity of intestinal microvillar membranes.
Another important notion is that vitamin D must be metabolized prior to its functioning to induce calcium transport in the intestine. DeLuca and coworkers (6, 7) have isolated from blood a vitamin D3 metabolite which is 1.4 times as active as native vitamin D3. They determined the structure of this compound to be 25-hydroxy-vitamin D3(25-OH D3) and proposed that it was the active form of vitamin D3 (8, 9) . Norman and associates (10) and later Kodicek and collaborators (11) used silicic-acid chromatography to detect a metabolite in chick intestine that was more polar than 25-OH D3. Haussler et al. (12) demonstrated that this metabolite was selectively associated with the nuclear chromatin of the target intestine and, more specifically, to a protein receptor molecule that was not a histone (13) .
In the present experiments, countercurrent distribution is employed to confirm the existence of a vitamin D3 metabolite in the intestine more polar than 25-OH D3. Isolation and biological assay of this metabolite reveals that it is the most efficacious and rapidly functioning metabolite of vitamin D3 yet tested and is, therefore, probably the active form of the vitamin in the chick intestine. Labeled steroids were administered dissolved in 1,2-propanediol. The chicks were killed by decapitation; the blood was collected with the aid of a funnel and the small intestine excised immediately. Intestinal-mucosa chromatin was prepared as described (12) and either the chromatin, whole intestine, or plasma was extracted with organic solvents by a modification of the procedure of Bligh and Dyer (14) . The lipid extract was dried under N2 in preparation for countercurrent distribution. Countercurrent distribution (CCD) Distribution studies were carried out on an H.O. Post, model no. 2-B,100-tube automated machine; 100 transfers were performed with a 10-ml mobile (upper) phase and a 10-ml stationary (lower)phase. Solvent system 1: ethyl acetate-hexaneethanol-water 5:15:11:9 or 2: same solvents 5:15:7.5:12.5 were used.
Metabolite from 1250 chick guts Triton X-100-washed chromatin (12) While some unmetabolized vitamin D3 is present, most of the tritium in the plasma migrates exactly with 25-OH D3. This major plasma metabolite, and the two more-polar peaks, are denoted peaks 4A, 4Bp and 4Cr, respectively, to be consistent with the original nomenclature devised by Haussler et al (12) for the peaks from silicic acid columns. On the basis of this and other work (16) , it is concluded that peak 4A is 25-OH D3.
The metabolite pattern in the vitamin D target organ, the intestinal mucosa, is quite different (Fig. 2A) . Small amounts of vitamin D3 and 25-OH D3 are present, but the majority of the tritium migrates with a K of 0.13 and is designated peak 4B1. This metabolite corresponds to intestinal-peak 4B of Norman (10), intestinal peak V of DeLuca (18) , and peak P of Kodicek (11) . Since (Fig. 2B) , reveals that virtually all of the radioactivity associated with the nuclear chromatin exists as peak 4B1. Also, on a per-chick basis, over 90% of the 4B, present in the intestine is localized in the chromatin. Thus, the presumed target site, where the active form of vitamin D3 may be functioning to control the expression of genetic information, contains a metabolite more polar than 25-OH D3. Fig. 3 shows duplicate experiments, which indicate that 25-OH D3 serves as a precursor for peak 4B1. Radioactive 25-OH D3 was generated by dosing either rachitic pigs (top left) or chicks (bottom left) with labeled vitamin D3, and securing the [3H]25-OH D3 from the plasma by CCD separations identical to the one depicted in Fig. 1B . The radioactive 25-OH D3 from each source was then injected into separate batches of chicks, the intestinal chromatin was prepared 16-hr later, and the lipid extracts of the chromatin were subjected to CCD with system 1 (right, Fig. 3 ). Clearly, peak 4B1 is found associated with the chromatin after administration of 25-OH D3. This experiment demonstrates that 25-OH D3 is an intermediate in the formation of the target-organ metabolite, peak 4B, and may explain the biological activity of 25-OH D3 in promoting intestinal Ca++ absorption. logical response to vitamin D. Fig. 4 depcits the results of an experiment that shows that subsequent to an oral dose of 50 IU of vitamin D3, peak 4B binds to the intestinal chromatin after only 4-hr and becomes maximal at 15-20 hr. The physiological response lags well behind, with initiation in the range of 9-16 hr after the dose, with maximal effect at 40 hr. Thus, there exists a 5-12 hr latent period between the presence of peak 4B, and the increase in Ca++ absorption in the gut.
Although the above experiments point to peak 4B, as the important intestinal metabolite of vitamin D3, in order to qualify as the active steroid peak 4B1 must itself be active.
Since peak 4B, is found only in the intestine, and its amount is limited by a finite number of receptor sites (10), obtaining sufficient material for biological assay is quite difficult. Fig. 5 illustrates the results of the last two purification steps of crude peak 4B1 obtained from 1250 chick guts. Silicic acid-column chromatography, by a modification of the method of Haussler et al. (12) , is shown in Fig. 5A; Fig. 5B displays CCD(solvent system 2) of the peak 4B, from silicic acid. It was previously determined that with system 2, peak 4BI migrates near the center of the train (K = 0.8), while the less-polar 25-OH D3 has a K of 15. 3.5 ,ug (140 IU) of the highly purified material in peak 4B, was obtained from the final CCD; this material was utilized for biological assays.
Initial assays on peak 4B1 were performed at 12, 24, and 40 hr after oral administration of the metabolite (Fig. 6A) . For comparison, time-course assays on doses of 50 IU of vitamin D3 and 25-OH D3 were also performed. Vitamin D3 elicited its characteristic induction of calcium transport with an 8-hr lag period, and maximal response at 40 hr. 25-OH D3 displayed a similar course of action, but acted slightly faster. However, the kinetics of the peak 4B, response was markedly different. It exhibited a rapid onset of induction, with maximal stimulation only 12 hr after the low dose of 7 IU per chick. It is estimated from the magnitude of the responses and doses of the three compounds tested that peak 4B, is at least 5 times as potent as vitamin D3 on a weight basis.
A second assay on peak 4B, at 2, 5, 8, 12, and 18 hr after dosing was performed in order to delineate earlier kinetics of peak 4B, functioning (Fig. 6B) at 8 hr. Thus, the intestinal metabolite is not only more active than both vitamin D3 and 25-OH D3, but it is capable of inducing Ca++ absorption from the gut far faster than either of the other (precursor) steroids.
DISCUSSION
The present communication reports the application of countercurrent distribution to the separation of vitamin D and its metabolites. CCD has been used previously for the isolation of a number of compounds of biological interest (19) . The results illustrated in Figs. 1 and 2 confirm the work of Myrtle et al. (16) , who reported that 25-OH D3 was the predominant vitamin D3 metabolite in the plasma, while a more polar steroid was associated with the target intestine. The intestinal metabolite is selectively localized in the nuclear-chromatin fraction (Fig. 2B) as previously established by Haussler et al. (12) . Recent work by Chen et al. (20) suggests that the association of the metabolite with isolated chromatin is dependent upon the method of chromatin preparation. This finding is not surprising when one considers the lability of the receptordeoxynucleoprotein complex (13) , but elucidation of the exact intranuclear binding site for the vitamin D metabolite requires further independent experiments such as radioautography.
The finding that 25-OH D3 can serve as a precursor of chromatin-associated peak 4B, (Fig. 3) implies that the native vitamin is first metabolized to 25-OH D3, followed by conversion of this intermediate form to peak 4BI. Thus, 25-OH D3 is related to the vitamin's ultimate induction of Ca++ absorption only in the sense that it is the initial metabolite in the sequence leading to peak 4B1,. The presence of small amounts of 25-OH D3 in the gut ( Fig. 2A) suggests that the conversion of 25-OH D3 to peak 4B, occurs in the target organ. We have shown here that the formation of peak 4B, precedes the onset of vitamin D-mediated Ca++ absorption (Fig. 4) , arguing against the criticism that peak 4B, appears too late to be involved in the induction process in the gut (18 Peak 4B1 proved to be a potent mediator of Ca++ absorption in the rachitic chick, for as little as 3-7 IU of the metabolite produced nearly maximal stimulation of Ca++ transport; this response occurred within 5-12 hr of oral administration of peak 4B1 (Fig. 6) . 30-50 IU of vitamin D3 or 25-OH D3, and a 24 to 40-hr time period, are required for a corresponding physiological response. The rapid decline in the action of peak 4B1 (Fig. 6) is most likely the result of metabolic elimination of the small amounts of peak 4B1. In contrast, larger doses of the precursor forms, such as vitamin D8 and 25-OH D3, probably provide a continual influx of newly-formed peak 4B, to sustain the Ca++ absorption response (Fig. 6A) . It can be seen also from Fig. 6B that the 5-12 hr necessary for activity of peak 4B, is identical to the time differential seen in Fig.  4 between the metabolite's appearance after a vitamin D3 dose and the induction of Ca++ transport. Finally, the 2-hr latent period between peak 4B, administration and the physiological response indicates that this metabolite may be functioning through an induction process as originally proposed for vitamin D3 (1).
The nature of peak 4B, (Fig. 1B) and its relationship to peak 4B1 will be discussed in a later publication. Although it appears to have a similar partition coefficient to peak 4Bi (Figs. 1B and 2A) , rechromatography of peak 4B1 either on CCD (with system 2) or on Celite (12) , indicates that it is heterogeneous and significantly less polar than peak 4B,. Also, in contrast to peak 4BI, no tritium loss from carbons 1 or 2 is seen in peak 4B1 (ref. 11 and manuscript in preparation). (21) . They propose that this dihydroxy-metabolite is preferentially active on bone.
The selective binding of peak 4B, in the target organ nucleus, coupled with its ability to act faster than other vitamin D-steroids, intimates that this unidentified compound is the form of the vitamin that initiates biochemical events in the intestine.
